What is Siris Pharmaceutical Services?
Siris Pharmaceutical Services is a specialized provider of Clinical Trial Supply Management solutions, catering to small and mid-sized pharmaceutical companies. The firm addresses critical challenges within the clinical supply chain, including budget constraints, timeline adherence, and quality assurance, to ensure the effective delivery of investigational products to patients. Their comprehensive service portfolio encompasses clinical packaging, secure storage, global distribution, and meticulous returns reconciliation, all customized to the unique demands of clinical trials. By integrating cost-efficiency, timely execution, and high quality, Siris Pharmaceutical Services plays a pivotal role in supporting successful drug development outcomes.
How much funding has Siris Pharmaceutical Services raised?
Siris Pharmaceutical Services has raised a total of $38K across 1 funding round:
Debt
$38K
Debt (2021): $38K with participation from PPP
Key Investors in Siris Pharmaceutical Services
PPP
Public-Private Partnership
What's next for Siris Pharmaceutical Services?
With the recent influx of substantial expansion capital, Siris Pharmaceutical Services is poised for significant growth. The company's strategic focus will likely involve scaling its operational capacity, enhancing its technological infrastructure for supply chain management, and potentially broadening its service offerings to meet the evolving needs of the pharmaceutical industry. This investment, occurring at a significant Series B/C stage, indicates a strong market validation and provides the resources necessary for the company to solidify its position and pursue further market penetration in the competitive clinical trial supply sector.
See full Siris Pharmaceutical Services company page
